Global Mesalazine Market Growth 2025-2031

The global Mesalazine market size is predicted to grow from US$ 182 million in 2025 to US$ 228 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.

With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.

Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

LP Information, Inc. (LPI) ' newest research report, the “Mesalazine Industry Forecast” looks at past sales and reviews total world Mesalazine sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalazine sales for 2025 through 2031. With Mesalazine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine industry.

This Insight Report provides a comprehensive analysis of the global Mesalazine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalazine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine and breaks down the forecast by Purity, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine.

This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Purity:
Above 97 %
Above 98 %
Above 99 %

Segmentation by Application:
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Mesalazine market?

What factors are driving Mesalazine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Mesalazine market opportunities vary by end market size?

How does Mesalazine break out by Purity, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.